3 results
Approved WMOPending
The primary objective of this pilot study is to evaluate the effects of 6 months of recombinant human IGF-I (rhIGF-I) treatment on the body composition.The secondary objective is to assess the effects of the treatment on the liver function,…
Approved WMOCompleted
To determine altered brain-activity during the performance of a sensitive perceptual-motor task following the administration of the antihistamine dexchlorpeniramine 4mg.
Approved WMORecruiting
Objective: The primary aim of the study is to demonstrate that cervical administered ITB is a safe treatment of spasticity of the UE without deterioration of pulmonary function, respiration and sleep-related breathing disorders.